Overview Reviews Product Description WY-14643, 250 mg Product Videos Custom Field Short Description PPAR alpha agonist Research Area Cancer, Cancer Metabolism, Cancer Carbohydrate Metabolism, Cancer Lipid and Lipoprotein Metabolism Alternative Name(s) 4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid, Pirinixic acid, 2-[4-chloro-6-[(2,3-dimethylphenyl)amino]pyrimidin-2-yl]sulfanylacetic acid, WY-14,643, WY14643, WY 14643, Wyeth 14,643 Category Small Molecules Product Type Agonist CAS No. 50892-23-4 Molecular Formula C14H14ClN3O2S Molecular Weight 323,8 Source Synthetic Purity 98.5% (HPLC); NMR (Conforms); MS (Conforms) Solubility Soluble in DMSO (40 mg/ml) Appearance Off white powder Storage -20ºC Shipping Shipped Ambient SMILES Cc1cccc(c1C)Nc2cc(nc(n2)SCC(=O)O)Cl InChI InChI=1S/C14H14ClN3O2S/c1-8-4-3-5-10(9(8)2)16-12-6-11(15)17-14(18-12)21-7-13(19)20/h3-6H,7H2,1-2H3,(H,19,20)(H,16,17,18) InChIKey SZRPDCCEHVWOJX-UHFFFAOYSA-N Field of Use For in vitro research use only. Product Reviews Write a Review Write a Review × WY-14643, 250 mg Rating * Select Rating 1 star (worst) 2 stars 3 stars (average) 4 stars 5 stars (best) Name Review Subject * Comments *
Quick view Details WY-14643, 50 mg MSRP: Now: NULL145.00 Add to Cart Quick view Details Biovision | WY-14643 | 2041 MSRP: Was: Now: NULL197.00 - NULL501.00 Choose Options Quick view Details Gefitinib, 250 mg MSRP: Now: NULL285.00 Add to Cart Quick view Details Edaravone, 250 mg MSRP: Now: NULL395.00 Add to Cart Quick view Details CAPE, 250 mg MSRP: Now: NULL314.00 Add to Cart ×
Quick view Details Biovision | WY-14643 | 2041 MSRP: Was: Now: NULL197.00 - NULL501.00 Choose Options
Quick view Details Gefitinib, 250 mg MSRP: Now: NULL285.00 Add to Cart Quick view Details Edaravone, 250 mg MSRP: Now: NULL395.00 Add to Cart Quick view Details CAPE, 250 mg MSRP: Now: NULL314.00 Add to Cart ×
Quick view Details Edaravone, 250 mg MSRP: Now: NULL395.00 Add to Cart Quick view Details CAPE, 250 mg MSRP: Now: NULL314.00 Add to Cart ×